Frontier Biotechnologies Inc. (SHA:688221)

Frontier Biotechnologies Revenue

Frontier Biotechnologies had revenue of 24.52M CNY in the quarter ending September 30, 2026, a decrease of -45.18%. This brings the company's total for the last twelve months to 357.83M, up 153.42% year-over-year. In the year 2025, Frontier Biotechnologies had annual revenue of 123.39M, down -4.70%. That makes Frontier Biotechnologies the 27,476th largest company in the world by revenue and 4,761st in China.

• Revenue (ttm): 357.83M
• Revenue Growth: +153.42%
• P/S Ratio: 13.79
• Revenue / Employee: 1.35M
• Employees: 265
• Market Cap: 4.93B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	123.39M	-6.09M	-4.70%
Dec 31, 2024	129.47M	15.22M	13.32%
Dec 31, 2023	114.25M	29.51M	34.82%
Dec 31, 2022	84.74M	44.24M	109.22%
Dec 31, 2021	40.50M	-6.12M	-13.13%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error